Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Stock Short Interest Jumps 298.3%

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) was the target of a large increase in short interest in September. As of September 30th, there was short interest totaling 705 shares, an increase of 298.3% from the September 15th total of 177 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 6,785 shares, the short-interest ratio is presently 0.1 days.

Santen Pharmaceutical Price Performance

Shares of OTCMKTS:SNPHY opened at $10.33 on Tuesday. The business has a 50-day simple moving average of $11.44 and a two-hundred day simple moving average of $11.74. Santen Pharmaceutical has a fifty-two week low of $9.22 and a fifty-two week high of $13.93.

About Santen Pharmaceutical

Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription ophthalmic medicines and related products used to treat eye diseases and disorders.

Its product portfolio addresses conditions including glaucoma, dry eye disease, retinal diseases, ocular allergies, infections and inflammation. Santen also develops treatments for other serious vision-related conditions and provides products for eye-care professionals and patients.

Founded in 1890 and headquartered in Osaka, Japan, Santen has built a business serving patients and healthcare providers in Japan and international markets, including other parts of Asia, Europe and North America.